Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.

Authors:
Bartley CM; Johns C; Ngo TT; Dandekar R; Loudermilk RL and 12 more

Journal:
JAMA Neurol

Publication Year: 2021

DOI:
10.1001/jamaneurol.2021.3821

PMCID:
PMC8546622

PMID:
34694339

View on PubMed View on PMC View Publisher
Journal Information

Full Title: JAMA Neurol

Abbreviation: JAMA Neurol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomiz…
Zhang X; Zhong W; Xue R and 38 more (2024) - Transparency Score: 3/6
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.
Cross AH; Gelfand JM; Thebault S and 30 more (2024) - Transparency Score: 1/6
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
Benallegue N; Rollot F; Wiertlewski S and 28 more (2024) - Transparency Score: 2/6
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk o…
Yan S; Jiang C; Janzen A and 8 more (2024) - Transparency Score: 1/6
Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized…
Fu Y; Wang A; Tang R and 25 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
16.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025